Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
NeonMind Biosciences Inc ( (TSE:LCR) ) has provided an announcement.
Lancaster Resources Inc. has announced the acquisition of the Lake Cargelligo Gold Project in the Cobar mining district of New South Wales, Australia. This project spans over 28,768 hectares and is known for its high-grade gold and silver occurrences. The acquisition is expected to enhance Lancaster’s exploration capabilities, with plans for a comprehensive exploration program. The strategic location and geological similarities to prominent gold deposits like Fort Knox and Tomingley position Lancaster favorably in the mining industry. The acquisition terms include a purchase price of CAD $210,000, a 2% NSR royalty, and contingent milestone payments. The closing of the acquisition is anticipated within 30 days, alongside a private placement to fund the project and related activities.
Spark’s Take on TSE:LCR Stock
According to Spark, TipRanks’ AI Analyst, TSE:LCR is a Underperform.
NeonMind Biosciences Inc exhibits a challenging financial situation with no revenue, high leverage, and negative cash flows, significantly impacting its overall score. Technical analysis provides some stability signals, but the lack of valuation metrics suggests caution. The overall risk profile suggests a need for strategic changes or additional funding to improve its financial health.
To see Spark’s full report on TSE:LCR stock, click here.
More about NeonMind Biosciences Inc
YTD Price Performance: -25.00%
Average Trading Volume: 99,959
Technical Sentiment Signal: Buy
Current Market Cap: C$835.6K
For detailed information about LCR stock, go to TipRanks’ Stock Analysis page.

